Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumours-Reference-Cited by-同舟云学术

Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumours

Published:2019-02-04 Issue:5-6 Volume:27 Page:690-698
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Benchimol Michael J.¹,Bourne David²³,Moghimi Seyed Moein⁴⁵⁶,Simberg Dmitri²⁴

Affiliation:

1. Sonrgy Inc, San Diego, CA, USA;

2. The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA;

3. Center for Translational Pharmacokinetics and Pharmacogenomics, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA;

4. Colorado Center for Nanomedicine and Nanosafety, Aurora, CO, USA;

5. School of Pharmacy, The Faculty of Medical Sciences, King George VI Building, Newcastle University, Newcastle upon Tyne, UK;

6. Division of Stratified Medicine, Biomarkers & Therapeutics, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

Funder

NIH

National Institute of Biomedical Imaging and Bioengineering

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2019.1566339

Reference59 articles.

1. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

2. Future Opportunities in Cancer Nanotechnology—NCI Strategic Workshop Report

3. Highlights of recent developments and trends in cancer nanotechnology research—View from NCI Alliance for Nanotechnology in Cancer

4. Opening Windows into Tumors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium;Nature Nanotechnology;2023-07-10

2. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment;Drug Resistance Updates;2023-01

3. Injectable rapidly dissolving needle-type gelatin implant capable of delivering high concentrations of H2O2 through intratumoral injection;Biomedicine & Pharmacotherapy;2022-12

4. The development and progress of nanomedicine for esophageal cancer diagnosis and treatment;Seminars in Cancer Biology;2022-11

5. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials;Pharmaceutics;2022-04-15